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Abstract 
Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD), and is associated 
with high morbidity and mortality rates. Key histological changes observed in DN include 
accumulation of extracellular matrix (ECM) proteins and tubulointerstitial fibrosis. Meprins are 
metalloproteinases that are abundantly expressed in the brush border membranes of proximal kidney 
tubules. Meprins are also expressed in leukocytes (monocytes and macrophages) and podocytes. 
Meprins cleave/degrade extracellular matrix (ECM) proteins such as collagen IV, collagen VI, 
fibronectin, laminin, and nidogen-1 in vitro. Meprins have been implicated in the pathology of DN. 
Sepsis is a complex medical condition, where the entire body undergoes an inflammatory state 
and the presence of a known or suspected infection leads to severe consequences such as 
multiple organ failure. Acute renal failure (ARF) is a common complication of sepsis. The 
objective of this study was to evaluate cecal ligation and puncture (CLP)-induced sepsis in meprin 
deficient mice with type 1 diabetes as a co-morbidity. Low dose Streptozotocin (STZ) was used to 
induce type-1 diabetes in wild-type (WT) C57BL/6 mice which express high levels of both meprin A 
and meprin B, and meprin α knockout mice on a C57BL/6 background, which are deficient in meprin 
A. Cecal ligation and puncture was performed 4 weeks post STZ injection. Blood was collected pre 
and post CLP to evaluate blood urea nitrogen (BUN) levels. The mice were sacrificed 18hr post CLP 
and kidney tissue processed for proteomic analysis. BUN levels were significantly higher in CLP 
mice and meprin α knockout mice had lower mortality rates in comparison to wild-type mice. The 
results show that meprin deficiency protected mice from kidney injury associated with CLP, 
suggesting that meprins play a role in kidney injury following CLP-induced sepsis.  
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CHAPTER 1 
Introduction 
Diabetes is the most rampant endocrine disease and affects millions of Americans alone. 
Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes and it is 
associated with a rise in the urinary albumin excretion (UAE) rate and abnormal renal function. 
Currently, changes in albuminuria are considered a hallmark of onset or progression of diabetic 
nephropathy. Approximately 20–30% of patients with type 1 or type 2 diabetes develop evidence 
of nephropathy (Ailing Lu and Anupam Agarwal 2011). Diabetic nephropathy is the leading 
cause of end stage renal disease (ESRD). Meprins are metalloproteinases that are highly 
expressed in the brush border membranes (BBM) of proximal kidney tubules (Bond & Beynon, 
1995; Kounnas et al., 1991). The self-associating homo-oligomeric complexes of meprin A are 
secreted as latent proteases (containing the prosequence) and can move through extracellular 
spaces in a non-destructive manner, and deliver a concentrated form of this metalloproteinase to 
sites that have activating proteases, such as site of inflammation, infection or cancerous growth. 
Thus, meprin structures provide means to concentrate proteolytic activity at the cell membrane 
(Bond & Beynon, 1995; Kounnas et al., 1991). Meprins have been shown to cleave ECM 
proteins such as collagen IV, collagen VI, fibronectin, laminin, and nidogen-1 in vitro (Banerjee 
& Bond, 2008; Kaushal et al., 1994; Kohler et al., 2000; Kruse et al., 2004). 
Sepsis is a complex medical condition, where the entire body undergoes an inflammatory 
state and the presence of a known or suspected infection leads to severe consequences such as 
multiple organ failure (Bone et al., 1992). Acute renal failure (ARF) is a common complication 
of sepsis and carries an ominous prognosis. Mortality was reported higher in patients with septic 
ARF (74.5%) than in those whose renal failure did not result from sepsis (45.2%) (Vriese, 
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2003a). Although studies have been conducted, the exact pathogenesis of diabetic nephropathy is 
complex and not completely understood.  Identifying anomalies of kidney function in the early 
stages of diabetic nephropathy is vital to developing an ideal treatment and cure. The objective of 
this research was to evaluate the role of meprins in the kidney injury associated with CLP-
induced sepsis using a meprin α deficient mouse model.  
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CHAPTER 2 
Literature Review 
2.1 Diabetes  
Diabetes is a chronic systemic disease characterized by high levels of glucose in the 
blood. Types 1 and 2 diabetes mellitus together affect more than 20 million Americans and rank 
as the sixth leading cause of disease-related death in the United States (Abdin et al., 2010; A. Red 
Eagle et al., 2005; Wada & Makino, 2013). People with diabetes have high blood glucose levels 
due to either the lack of insulin production by the pancreas or the inability of cells to process 
insulin. Patients with high blood sugar will typically experience polyuria (frequent urination), 
they will become increasingly thirsty (polydipsia) and hungry (polyphagia). In the body, the 
metabolic hormone insulin is imperative to blood glucose homeostasis. Insulin is produced by 
pancreatic β cells in the body(H.M. Wagner E., Bloom D., and Camerini D, 1998).  
The onset of type-1 diabetes is directly linked to the malfunction of these pancreatic β cells in the 
body. People usually develop type 1 diabetes before their 40th year, often in early adulthood or 
teenage years. Type 1 diabetes requires treatment with insulin or transplantation of pancreatic b 
cells. Patients with type 1 diabetes will need to take insulin injections for the rest of their 
life(H.M. Wagner E., Bloom D., and Camerini D, 1998). They must also ensure proper blood-
glucose levels by carrying out regular blood tests and following a special diet. By contrast, the 
majority of the diabetic population has type 2 diabetes, which is not insulin-dependent. In most 
cases this form of diabetes does not require insulin therapy. Type 2 diabetes is characterized by 
persistent hyperglycemia, impaired glucose tolerance, glomerular hyperfiltration, and 
progression of albuminuria, ultimately leading to renal injury(Schena, 2005). 
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The prevalence of diabetes is projected to increase from 171 million in 2000 to 366 
million in 2030, as a result of growth, aging, urbanization, and physical inactivity (Wild et al., 
2004). Type-1 and type-2 diabetes continue to increase on an epidemic scale and have become a 
major public health concern globally. Identifying new therapeutic targets are critical to 
suppressing this epidemic.   
2.1.2 Complications of Diabetes Diabetes is associated with several complications.  
These include: weight loss, polyuria, hypertension, blurred vision and diabetic nephropathy 
(DN). 
2.2 Diabetic Nephropathy 
Diabetic nephropathy is one of the most severe microvascular complications of diabetes 
mellitus and is also a major cause of end-stage renal disease(Schena, 2005). Diabetic 
nephropathy is associated with albuminuria, proteinuria and reduction in glomerular filtration 
rate (Ching Ye Hong, 1998). The elevated levels of serum creatinine and blood urea nitrogen are 
considered to be an index of diabetic nephropathy. In the glomeruli, mesangial cells are 
considered to be a primary target for the insult induced by increased glomerular capillary 
pressure and play a crucial role in the glomerular trafficking of plasma proteins, their deposition, 
and extracellular matrix (ECM) protein accumulation within the mesangium (Luca Paris, 2008). 
This leads to the development and progression of glomerular sclerotic lesions in various 
glomerular diseases such as diabetic nephropathy. The  thickening  of  basement  membranes  in  
capillaries  and  small  vessels  of  diabetic  patients  is considered  to  be a characteristic 
histological  finding in diabetic nephropathy (Rafel  Sim, 1996). 
Ethnic disposition to ESRD varies greatly across different racial groups. In figure 1 
shown below, both the rates of incident of ESRD caused by diabetes and their growth over time 
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vary widely by age and race/ethnicity (Health, 2013). Among whites age 30–39, for example, the 
rate (adjusted for gender) has increased just 3.5 percent since 2000, reaching 37 per million in 
2011. For blacks/African Americans of the same age, in contrast, the rate has increased 72 
percent since 2000, to reach 136 per million. Different patterns are seen among older populations 
in the same figure. The 2011 rate of incident ESRD due to diabetes among whites age 50–59 is 
nearly the same as in 2000, while rates have fallen 27 and 50 percent, respectively, among 
blacks/African Americans and Native Americans of the same age(Health, 2013). The wide 
variation of incidence of ESRD caused by diabetes is not fully understood.  
 
Figure 1. Adjusted incident rates of ESRD due to diabetes, by age, race, & ethnicity. 
2.2.1 Histology of Diabetic Nephropathy Diabetic nephropathy development is 
characterized by the progressive change in kidney function. This change occurs in series of 
stages. During the initial stages, diabetics experience hyperglycemia and glomerular 
hyperfiltration(Ayo, 1990).  Subsequent stages include thickening of the glomerular basement 
membrane, mesangial cell expansion, proteinuria, acute and severe hypertension, and the 
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eventual decline in glomerular filtration rate (GFR). These stages ultimately lead to end stage 
renal disease (ESRD) (Ching Ye Hong, 1998). It should also be noted that the loss of renal 
functionality leads to a decline in nephrons and accumulation of extracellular matrix (ECM). 
ECM abundance has been linked to upregulation of transforming growth factor-β (TGF-β), a 
fibrogenic cytokine (Eddy & Neilson, 2006; Lan, 2011). Production of TGF-β stimulates ECM 
synthesis while inhibiting degradation (Lan, 2011). Treatment with anti-TGF-β in db/db mice, a 
mouse model of type-2 diabetes showed decreased glomerular basement membrane thickening 
and mesangial matrix accumulation (Chen et al., 2003). Extracellular matrix buildup in the 
diabetic kidney surpasses degradation and initiates glomerulosclerosis and tubulointerstitial 
fibrosis (Chen et al., 2003).  
Hyperglycemia also causes an increase in the synthesis of fibronectin, laminin, and type 
IV collagen in glomerular mesangial cells. Laminin,  an  adhesive  glycoprotein,  is  the  main  
non-collagenous constituent  of  the  basement membrane and is up regulated in diabetic patients 
(Rafel  Sim, 1996).  In recent  years,  biochemical  and  immunohistochemical  approaches  have  
been developed  to  characterize  the  changes  of  laminin  in  basement  membrane and  
alterations  of  the  metabolism  and  distribution of  this  protein  have  been  described  in  
diabetic  animals  and  also  in  humans (Rafel  Sim, 1996). Fibronectin is involved in 
coagulation, platelet formation, tissue repair, and may reduce erythrocyte deformity and 
filterability in diabetic patients (Ching Ye Hong, 1998). Glomerular mesangial cells are 
considered to be exposed to the stretch stress due to glomerular hypertension and are found to 
produce the excess amount of extracellular matrix (ECM) proteins including fibronectin when 
exposed to the mechanical stretch. This is important because increases in mesangial cell 
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proliferation and extracellular matrix proteins, such as  fibronectin , ultimately result in 
thickening of the glomerular basement membrane (Ailing Lu & Anupam Agarwal, 2011). 
Understanding the pathogenesis of diabetic nephropathy, along with its complications, in the 
early stages is necessary to develop targeted therapies to detect alterations in kidney function. It 
remains to be fully defined as to which pathways in diabetic complications are essentially 
protective rather than pathological, in terms of their effects on the underlying disease process. 
Today, clinical indicators of diabetic nephropathy include blood urea nitrogen (BUN), 
proteinuria, serum creatinine, and glomerular filtration rate (GFR) measurements to asses kidney 
function(Bluestone, 2010).  
2.2.2 Role of Mesangial Cells in Diabetic Nephropathy In the glomeruli, mesangial 
cells are considered to be a primary target for the insult induced by increased glomerular 
capillary pressure and play a crucial role in the glomerular trafficking of plasma proteins, their 
deposition, and extracellular matrix (ECM) protein accumulation within the mesangium (Luca 
Paris, 2008). Secretion of ECM proteins by mesangial cells could thus, lead to the development 
and progression of glomerular sclerotic lesions in various glomerular diseases such as DN. The  
thickening  of  basement  membranes  in  capillaries  and  small  vessels  of  diabetic  patients  is 
considered  to  be a characteristic histological  finding in DN (Rafel  Sim, 1996).  
Fibronectin is involved in coagulation, platelet formation, tissue repair, and may reduce 
erythrocyte deformity and filterability in diabetic patients (Ching Ye Hong, 1998). It is believed 
that mesangial cell proliferation and extracellular matrix accumulation play crucial roles in early 
renal hypertrophy and later glomerular sclerosis in diabetic nephropathy. Mesangial cells excrete 
more extracellular proteins under high glucose conditions, but the mechanism behind this is not 
understood. Glomerular mesangial cells are considered to be exposed to the stretch stress due to 
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glomerular hypertension and are found to produce the excess amount of extracellular matrix 
(ECM) proteins including fibronectin and laminin when exposed to the mechanical stretch (Luca 
Paris, 2008). This is important because increases in mesangial cell proliferation and extracellular 
matrix proteins, including  fibronectin , ultimately result in thickening of the glomerular 
basement membrane (Ailing Lu & Anupam Agarwal, 2011). This ultimately leads to impaired 
renal function.  Previous studies have demonstrated that high glucose levels stimulated 
mesangial cell proliferation and fibronectin expression leading to extracellular matrix deposition. 
Laminin,  an  adhesive  glycoprotein,  is  the  main  non-collagenous constituent  of  the  
basement membrane and is up regulated in diabetic patients.  In recent  years,  biochemical  and  
immunohistochemical  approaches  have  been developed  to  characterize  the  changes  of  
laminin  in  basement  membrane and  alterations  of  the  metabolism  and  distribution of  this  
protein  have  been  described  in  diabetic  animals  and  also  in  humans (Rafel  Sim, 1996). 
The most  widely  used  marker  for  laminin  metabolism in  humans  is  the  LPl  fragment  and  
its  assay  in serum  has  proved  useful  in  the  monitoring  of  patients  with malignancies  and  
liver  disease. These pathways ultimately lead to increased renal albumin permeability and 
extracellular matrix accumulation, resulting in increasing proteinuria, glomerulosclerosis and 
ultimately tubulointerstitial fibrosis (Luca Paris, 2008). 
2.2.3 Signaling Pathways Involved in Extracellular Matrix Metabolism The protein 
kinases regulate a series of cellular processes during growth and development. Protein kinases 
are an integral part of the machinery that is activated in response to stress, they are essential for 
memory, and they are directly involved in orchestrating cell death (S.S. Taylor, 2006). These 
enzymes are primary targets for therapeutic intervention. Examining the localization and 
signaling between these protein kinases will provide some explanation in the hyper-excretion of 
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these extracellular basement proteins which ultimately lead to renal fibrosis and diabetic 
nephropathy. Several treatment strategies are available to cure diabetic nephropathy or reduce its 
progression. These include modalities used to suppress the renin–angiotensin–aldosterone system 
and control blood glucose levels (Eades, 2009). However, diabetic patients are still reaching end 
stage renal disease at an alarming rate. Conventional therapeutic strategies are not fully 
efficacious in the treatment of diabetic nephropathy, suggesting an incomplete understanding of 
the gene regulation mechanisms involved in its pathogenesis (Eades, 2009). 
2.2.4 Sepsis and the Immune Response Sepsis is a complex medical condition, where 
the entire body undergoes an inflammatory state and the presence of a known or suspected 
infection leads to severe consequences such as multiple organ failure (Bone et al., 1992). Sepsis 
serves as diabetes most common co-morbidity. Acute renal failure (ARF) is a common 
complication of sepsis and carries an ominous prognosis. Mortality was reported higher in 
patients with septic ARF (74.5%) than in those whose renal failure did not result from sepsis 
(45.2%) (Vriese, 2003b). Inflammatory cells infiltrate the kidney, causing local damage by 
release of oxygen radicals, proteases, and further production of inflammatory cytokines. 
Cytokines act as polypeptides regulating inflammatory and immune responses through actions on 
cells (Hewlett M. Wagner E., Bloom D., and Camerini D, 2004). Inflammatory cytokines, 
mainly IL-1, IL-6, and IL-18, as well as TNF-α, are involved in the development and progression 
of diabetic nephropathy (Vriese, 2003b). As shown below in figure 2, the three significant steps 
in sepsis are vasodilation and vascular leak, leukocyte recruitment, and coagulation and 
neutrophil extracellular trap (NET) formation. Local inflammatory mediators, including tumor 
necrosis factor (TNF) and interleukin (IL)-1β, lead to vasodilation (Hewlett M. Wagner E., 
Bloom D., and Camerini D, 2004). This recruits leukocytes to sites of infection and sets off a 
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cascade of leukocyte activation, NET formation, and coagulation (Vriese, 2003b). The 
recognition of these molecules as significant pathogenic mediators in diabetic nephropathy 
leaves open the possibility of new potential therapeutic targets (Hewlett M. Wagner E., Bloom 
D., and Camerini D, 2004). Those suffering from systemic sepsis suffer from acute lung injury, 
acute kidney injury, and even death.  
 
Figure 2. Schematic of Sepsis. 
 
People with diabetes may also be at increased risk of developing acute renal failure 
(ARF). The presence of underlying diabetic nephropathy may predispose to ARF resulting from 
adverse effects such as hypotension, sepsis or exposure to nephrotoxic agents (Ching Ye Hong, 
1998). Understanding the role that the immune system plays in the pathogenesis of diabetic 
nephropathy could lead to identification of new strategies and/or additional therapeutic targets 
for prevention and treatment of diabetic nephropathy (Hewlett M. Wagner E., Bloom D., and 
Camerini D, 2004). 
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2.3 Meprins 
Meprins are cell surface and secreted proteases highly expressed in the brush border 
membranes of proximal kidney tubules (Bertenshaw et al., 2001; Bond, Matters, Banerjee, & 
Dusheck, 2005; Kounnas, Wolz, Gorbea, & Bond, 1991). Meprins are members of the astacin 8 
family of metalloproteases (Bond & Beynon, 1995). Meprin A and meprin B are disulfide-
linked, tetrameric metalloendopeptidases in renal brush border membranes. Meprins are highly 
expressed at the brush border membrane of proximal tubule cells of the kidney and epithelial 
cells of the intestine (Carlos M. Gorbea, 1991). Meprin proteases are composed of two 
evolutionarily related subunits, α and β, that are approximately 50% identical at the amino acid 
level. The subunits are encoded on two genes: the α gene is on human chromosome 6 (mouse 17) 
near the histocompatibility complex; the β subunit on chromosome 18 in both the mouse and 
human genomes (Judith S. Bond, 2005). The self-associating homo-oligomeric complexes of 
meprin A are secreted as latent proteases (containing the prosequence) and can move through 
extracellular spaces in a non-destructive manner, and deliver a concentrated form of this 
metalloproteinase to sites that have activating proteases, such as site of inflammation, infection 
or cancerous growth (Carlos M. Gorbea, 1991). In situ hybridization studies of embryonic and 
adult mice and immunohistochemistry demonstrated the tissue-specific expression of meprin 
subunits in the epithelial cells of kidney and intestine only. Kidney expressions of mouse meprin 
subunits are strain-dependent; all strains express both subunits during fetal stages. Some strains 
increase both subunits after birth (e.g., C57BL/6) while others only express meprin β, and down 
regulate mepin α (e.g., C3H/He) (Judith S. Bond, 2005). Meprin structures provide means to 
concentrate activity at the cell membrane.  
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Researchers also determined the tissue-specificity of meprin subunits in embryonic and 
adult mice. The study established that the expression of kidney meprin subunits is dependent on 
the strain of mice; C57BL/6 mice expresses both α and β meprin subunits whereas adult C3H/He 
lack the meprin α subunit (Kumar & Bond, 2001). Within the kidney, meprin expression is 
normally restricted to the brush-border membrane, however when injury occurs, meprins are 
transferred to other cell compartments. This transfer of meprins to other cellular compartments 
can increase damage to kidney tissue.  
2.3.1 Meprins Structures Meprins are composed of two subunits, alpha (α) and beta (β), 
that are evolutionarily related but differ in function and structure (Bond & Beynon, 1995; Wolz 
& Bond, 1995). The α and β subunits are encoded by two distinct genes on chromosomes 6 and 
18 in humans and 17 and 18 in mice (Bond, Rojas, Overhauser, Zoghbi, & Jiang, 1995). Meprin 
A consists of homo-oligomeric α/α complexes and hetero-oligomeric α/β complexes, while 
meprin B is a homo-oligomer of β/β complexes (Beynon, Oliver, & Robertson, 1996; Bond & 
Beynon, 1995; Gorbea et al., 1993). Meprin β subunits are integral membrane proteins that 
consist of a short cytoplasmic tail and a trans-membrane domain (Johnson & Hersh, 1994; 
Marchand, Tang, & Bond, 1994). The meprin subunits form homo or hetero complexes linked by 
disulfide bonds and can be expressed separately or coordinately (Bond et al., 2005). When the 
subunit α is associated with a β subunit, it remains attached to the cell membrane. 
2.3.2 Meprins Substrates Meprins are highly conserved among different species and are 
capable of degrading a wide range of proteins, such as ECM proteins collagen IV, collagen VI, 
fibronectin, laminin, and nidogen-1 in vitro (Banerjee & Bond, 2008; Kaushal, Walker, & Shah, 
1994; Kohler, Kruse, Stocker, & Sterchi, 2000; Kruse et al., 2004). Both α and β subunits have 
specific substrates that are capable of being degraded such as bradykinin (Bertenshaw, Villa, 
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Hengst, & Bond, 2002) for meprin A and gastrin (Bertenshaw et al., 2001) , orcokinin 
(Bertenshaw et al., 2002), pro-inflammatory cytokines (Marchand et al., 1994; Norman, Matters, 
Crisman, & Bond, 2003), E-cadherin (Huguenin et al., 2008) and protein kinases (Chestukhin, 
Litovchick, Muradov, Batkin, & Shaltiel, 1997) for meprin B. Meprins also cleave parathyroid 
hormone (Yamaguchi, Fukase, Sugimoto, Kido, & Chihara, 1994), biologically active peptides 
(Kohler et al., 2000; Sterchi, Naim, Lentze, Hauri, & Fransen, 1988) and chemokines. The 
localization of meprins at the interface with the external environment, at leukocytes at 
inflammatory sites, and in response to bacterial infections implicates them in host defense.  
2.3.3 Meprins and Diabetic Nephropathy Meprins have been linked with a variety of 
pathological conditions such as ischemia-reperfusion, induced acute renal failure, diabetic 
nephropathy, and fibrosis. Other studies demonstrate that low levels of meprin A are associated 
with the development of chronic nephropathy and fibrosis in animal models of diabetes (Bond et 
al., 2005; Mathew et al., 2005). Researchers used polymerase chain reaction to determine 
variations in the meprin β gene in Pima Indians, a Native American tribe with significantly high 
rates of type 2 diabetes and diabetic nephropathy (A. R. Red Eagle et al., 2005). This critical 
study revealed 19 single nucleotide polymorphisms (SNPs) in the meprin β gene, suggesting that 
there are genes that make individuals susceptible to diabetic nephropathy (A. R. Red Eagle et al., 
2005). Urine samples were collected from premenopausal women with histories of urinary tract 
infections (Bond et al., 2005). Researchers found that women with acute urinary tract infections 
had high or very high levels of meprin in the urine (Bond et al., 2005). 
2.3.4 Meprins and Cecal Ligation and Puncture Induced Sepsis Sepsis is a disorder 
initiated by excessive activation of innate immunity. It is a serious medical problem particularly 
in patients in the intensive care unit (ICU)
 
where it is the second leading cause of death in non-
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coronary ICU patients. Acute renal injury (AKI) occurs in 20%–50% of septic patients and 
nearly doubles the mortality rate of sepsis (A. R. Red Eagle et al., 2005). There is a growing 
recognition of the need for treatment regimens that target both the early systemic and later 
kidney-specific effects of sepsis in patients. Meprins are also capable of proteolytically 
processing cytokines and chemokines (Hewlett M. Wagner E., Bloom D., and Camerini D, 
2004). For example, meprin A and meprin α are capable of generating biologically active IL-1β 
from its precursor pro-IL-1β (Herzog C, 2009). Recent studies have demonstrated that meprin-α 
knockout mice were protected against lipopolysaccharide (LPS)-induced AKI. This finding 
supported a recent study shown that actinonin administered at the time of induction of sepsis by 
cecal ligation and puncture (CLP) in mice reduced renal injury (Holly MK, 2006). However, this 
study did not address the mechanism of protection. Since current therapy is mostly supportive 
and largely ineffective there is a critical need to uncover new therapeutic approaches because the 
incidence of sepsis-induced AKI is predicted to increase as the population ages (Jandeleit-Dahm, 
2006).  
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CHAPTER 3 
Methodology 
3.1 Reagents  
The following chemicals were purchased from Sigma-Aldrich (St Louis, MO): mannitol, 
sodium citrate, sodium chloride, sodium dodecyl sulfate, streptozotocin (STZ) 
tetramethylethylenediamine (TEMED) and triton X-100. The following chemicals were 
purchased from Fisher Scientific (Pittsburgh, PA): β-mercaptoethanol, acetic acid, ammonium 
persulfate, choloroform, ethylenediaminetetraacetic acid (EDTA), EZ-Run pre-stained rec 
protein ladder, fat-free milk, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES), 
isobutyl alcohol, hydrochloric acid, magnesium chloride, methanol, sodium orthovanadate, tris 
base, and tween 20. The following chemicals were purchased from Bio-Rad (Hercules, CA): 
anti-mouse IgG secondary antibody, anti-rabbit secondary antibody, Bio-Rad’s protein reagent, 
30% acrylamide (29:1 bis solution). Dr Judith Bond from Pennsylvania State University College 
of Medicine (Hershey, PA) donated anti-meprin-A polyclonal rabbit and anti-meprin-B 
polyclonal rabbit antibodies. Anti-PKA mouse monoclonal antibody was purchased from BD 
Biosciences (Greensboro, NC). The following chemicals were purchased from Thermo Scientific 
(Waltham, MA): ethyl alcohol 200 proof (Acros Organics), 100X EDTA solution, 100X halt 
protease inhibitor cocktail and West Pico ® chemiluminescent substrate. 
3.2 Experimental Animals  
Wild-type male mice on a C57BL/6 background were purchased from Charles River 
Laboratories (Wilmington, MA). Meprin α knockout (αKO) mice on a C57BL/6 background 
were bred in Laboratory Animal resource Unit (LARU) at North Carolina Agricultural & 
Technical State University.  All mice were housed in standard cages with 5 mice per cage with a 
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12:12 hour light:dark cycles and were fed a standard mouse chow (Purina Laboratory Chow 
5001; Purina Mills, St Louis, MO) and water ad libitum. All animal protocols were approved by 
the North Carolina A&T State University Institutional Animal Care and Use Committee 
(IACUC). 
3.3 Induction of Diabetes in Mice  
Low dose streptozotocin (STZ) was used to induce type-1 diabetes in 8 week old mice. 
STZ was dissolved in sodium citrate buffer (10 mmol/L, pH 4.5) to make a stock of 7.5 mg/mL. 
STZ was used within 15 minutes of preparing and kept from light to avoid degradation. Mice 
were injected with STZ at 55 mg/kg using a 29G insulin needle, to induce type-1 diabetes. 
Control mice were injected with equivalent volumes of sodium citrate buffer. Injections were 
repeated for 5 consecutive days. All mice were fasted for 6 hours prior to injections. Mice were 
weighed prior to injections and every week thereafter. Blood glucose levels were measured for 
each mouse at 10 days post-STZ injections using a Reli-On
®
  Blood Glucose Monitoring System 
(ARKRAY USA, Minneapolis, MN). STZ-injected mice with a blood glucose level ˃250 mg/dL 
were considered diabetic. 
3.4 Cecal Ligation and Puncture  
Mice were anesthetized with Ketamine (100 mg/kg) and Xylazine (100 mg/kg) dissolved 
in 0.9 % sterile saline solution intraperitoneal. The lower abdominal quadrant of each mouse was 
shaved using an electric trimmer and disinfected with Betadine and Nolvasane 3x. Applied eye 
ointment to the eyes and monitored the intensity of anesthesia by a toe pinch. A midline 
longitudinal incision was made to exteriorize the cecum and contents within the cecum were 
pushed toward the blind end ~15cm from end. The ligated cecum was perforated by a single 
through-and-through puncture with a 21-gauge needle and squeezed to extrude a 1 mm column 
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of fecal material. In sham-operated mice, the cecum was located, but neither ligated nor 
punctured. The cecum was relocated into the abdominal cavity. The abdominal incision was 
closed in two layers with 5-0 nylon sutures running sutures. After surgery, 1 ml of pre-warmed 
0.9% sterile saline solution was injected intraperitoneally. Mice were allowed to recover then 
returned to cages with food and water on pre-warmed deltaphase isothermal pads. Six hours 
post-CLP mice were given Buprenorphrine (0.3 mg/ml) dissolved in 0.9 % sterile saline solution 
intraperitoneal for pain.  
3.5 Tissue Collection and Analysis  
Blood and urine samples were collected at 4 weeks post-STZ injections. Blood samples 
were collected from each C57BL/6 mouse by nicking the tail vein and drawing into 
lithium/heparin tubes (Sarstedt, Newton, NC), which prevent clotting of the blood. Blood was 
collected at 4 weeks post-STZ injections for both male and female mice. Blood samples were 
centrifuged at 10000 x g for 10 minutes at 4˚ C. Plasma was stored at -80 ˚C until used for 
kidney assessments. Spot urine samples were collected by bladder massage. To harvest kidney 
tissue, the mice were put to death by inhalation of CO2. Both left and right kidneys were 
removed and decapsulated. Half of the kidney was wrapped in aluminum foil, snap-frozen in 
liquid nitrogen and stored at -80 ˚C for proteomic analysis. Other sections of each kidney were 
cut and placed into Carnoy’s fixative (60% Methanol, 30% Chloroform, 10% Acetic Acid) 
overnight. The kidney sections were then removed from the fixative and stored in 70% Ethanol 
at 4˚C. Kidney tissue was embedded in paraffin embedded and 5 μm cross sections were cut onto 
Superfrost plus microscope slides (Fisher Scientific, Pittsburgh, PA) for histology. 
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3.6 Blood Urea Nitrogen Assay  
To evaluate kidney function, blood urea nitrogen (BUN) was measured at 4 weeks post-
STZ injections using the stored plasma samples. BUN was assessed using BUN chemistry slides 
(Ortho Clinical Diagnostics, Rochester, NY) and then analyzed on the Vitros DT6011 Analyzer 
(Ortho Clinical Diagnostics, Rochester, NY). 
3.7 Fractionation of Kidney Proteins  
Mice kidneys, previously stored at -80 ˚C were thawed and fractionated into cytosolic-, 
brush border membrane- and structural-enriched fractions. Additionally, samples containing total 
protein content were obtained. Kidneys were homogenized in 9 volumes of Kidney Brush Border 
Homogenization Buffer (2mM Tris HCl, pH 7.0 with 10 mM Mannitol). A 1 M stock of MgCl2 
was added for a final concentration of 10 mM and stirred at 4 ˚C for 14 minutes. The 
homogenate was centrifuged at 15000 x g at 4 ˚C for 15 minutes and the supernatant was 
transferred to a new microcentrifuge tube. The supernatant was centrifuged at 15000 x g at 4˚C 
for 15 minutes; afterward the supernatant was transferred into a new microcentrifuge tube and 
stored at -80 ˚C as the cytosolic-enriched fraction. The pellet was resuspended in 500 μL Kidney 
Brush Border Homogenization Buffer and centrifuged at 2200 x g at 4 ˚C for 15 minutes. The 
supernatant was centrifuged at 2200 x g for 15 minutes and discarded. The pellet was 
resuspended in 100 μL Kidney Brush Border Homogenization Buffer and stored at -80 ˚C as the 
brush border membrane-enriched fraction. Radioimmunoprecipitation Assay buffer (RIPA) (0.02 
mM HEPES pH 7.9, 0.015 mM NaCl, 0.1 mM Triton-X 100, 0.01 mM SDS, 1 mM Na3VO4) 
with 10% 0.5 M EDTA was used to extract total protein mix and kept on ice for 30 minutes. The 
homogenate was centrifuged at 16100 x g at 4 ˚C for 10 minutes and supernatant was transferred 
into a new microcentrifuge tube then stored at -80 ˚C. Supernatant is the total-enriched fraction. 
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Proteins concentrations from all fractions were determined by the Bradford Reagent Protein 
Assay Method, using Bio-Rad’s Protein Assay Reagent (Hercules, CA). 
3.8 Western Blot Analysis  
Western blot analysis was used to quantify the kidney protein levels of meprin A, meprin 
B and the catalytic subunit of protein kinase A (PKAcat). Equal amounts of kidney protein (30-
80 μg) were loaded into 10% prepared Sodium Dodecyl Sulfate Polyacrylamide Gels (SDS-
PAGE) and allowed to separate by electrophoresis for 1 hour at 200 Volts. Proteins from the gels 
were transferred to nitrocellulose membrane (Bio-Rad, Richmond, CA) using a Trans-Blot SD 
Semi-Dry Transfer Cell Unit (Bio-Rad, Richmond, CA). To block nonspecific binding sites, 
membranes were incubated in 8% fatty-free milk in Tris-buffered saline with 0.1% Tween 20 
(TBS-T) for 1 hour at room temperature with gentle shaking. Nitrocellulose membranes were 
incubated with primary antibodies overnight at 4˚C or at room temperature for 1 hour. The 
primary antibodies used were polyclonal rabbit anti-meprin α and β (Hershey Medical Center, 
Hershey, PA), diluted 1:5000 and mouse monoclonal anti-PKAcat (BD Biosciences Greensboro, 
NC), diluted 1:3300. The nitrocellulose membranes were washed three times for 10 minutes at 
room temperature. The secondary antibody mouse IgG (Bio-Rad, Hercules, CA) or rabbit IgG 
(Bio-Rad, Hercules, CA) was added to the nitrocellulose membranes using a dilution of 1:10,000 
overnight at 4˚C or at room temperature for 1 hour. The nitrocellulose membranes were washed 
three times for 15 minutes at room temperature. Nitrocellulose membranes were then exposed to 
Chemiluminescent Substrates (Thermo Scientific, Waltham, MA) and developed on X-Ray film. 
Protein bands were evaluated by densitometry using QuantityOne Software (Bio-Rad, Hercules, 
CA). 
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3.9 Statistical Analysis  
The data were analyzed by two-way ANOVA, with Bonferroni post-test pair-wise 
comparisons using Graph Pad Prism Software (GraphPad Software, La Jolla, CA). P values ≤ 0.5 
were considered statistically significant. 
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CHAPTER 4 
Results 
4.1 Blood Glucose  
Diabetes was confirmed by measuring blood glucose ten days post-STZ injections for 
each mouse. Mice with a blood glucose reading > 250 mg/dL are considered diabetic. Blood 
glucose levels for STZ-injected WT and meprin αKO mice were significantly higher in 
comparison to sodium citrate (NaC) buffer injected mice. Wild-type and meprin αKO  mice 
subjected to CLP surgery had higher glucose levels than sham operated controls. 
 
 
 
 
 
 
 
 
Figure 3. WT and αKO 10 Day Glucose Measurements (**= P<0.01;***=P<0.001)  
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4.2 WT Pre- vs. Post-Diabetic Body Weights 
Body weights were collected at 0 and 4 weeks post STZ injection in WT mice examine 
the effects of diabetes on body weight. 
 
 
 
 
 
 
 
 
Figure 4. WT body weights 0 weeks diabetic vs. 4 Weeks diabetic. (ns= P<0.05;***=P<0.001) . 
4.3 WT BUN Levels Pre- vs. Post-CLP 
Plasma samples were processed 0 and 18 hours post CLP to assay BUN in C57BL/6 (WT) 
mice. BUN levels were higher in the WT mice 18 hours post CLP surgery.  
 
 
 
 
 
 
  
 
Figure 5. WT BUN levels 0 hour and 18 hour CLP (ns= P<0.05;***=P<0.001)  
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4.4 αKO BUN Pre- vs. Post-CLP 
Plasma samples were processed 0 and 18 hours post CLP to assay BUN in αKO mice. BUN 
levels were higher in the αKO mice 18 hours post-CLP surgery.  
 
 
 
 
 
 
 
 
Figure 6. αKO BUN levels 0 hour and 18 hour CLP (ns=P<0.05;**=P<0.01)  
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Figure 7. WT BUN levels non-diabetic vs. diabetic (ns= P<0.05;***=P<0.001).  
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4.6 Serum Creatinine Levels 
 
 
 
 
 
 
 
 
 
Figure 8. Serum creatinine levels in WT mice pre and post CLP. 
4.7 CLP Mortality Rates 
Mortality rates were evaluated for both the sham and CLP induced sepsis mice. 30% of 
mice that had undergone CLP induced sepsis died overnight in comparison to 10% of the sham 
mice. 
 
 
 
 
 
 
Figure 9. CLP was associated with a high mortality rate.  
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4.8 Genotype CLP Mortality Rates 
Mortality rates were determined by genotype. 20% of the C57BL/6 (WT) mice died 18 
hours post CLP surgery in comparison to 10% of αKO mice. 
 
 
 
 
 
 
 
Figure 10. Meprin A deficiency decreased CLP-associated mortality 
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CHAPTER 5 
Discussion and Future Research 
Diabetic nephropathy is the leading cause of ESRD worldwide (Ibrahim & Hostetter, 
1997, Molitch et al., 2003; A. R. Red Eagle et al., 2005; Thrailkill et al., 2009). It has become an 
increasing concern in medicine because it is associated with high mortality and morbidity rates. 
Pathological changes observed in diabetic nephropathy include: accumulation of ECM proteins, 
proteinuria, renal hypertrophy, glomerular basement membrane thickening, mesangial expansion 
and renal fibrosis (Lan, 2011; Maxwell, 2005; Wada & Makino, 2013). Meprin metalloproteases 
are abundantly expressed in the BBM of the kidney and have been shown to degrade ECM 
proteins. Sepsis is a disorder initiated by excessive activation of innate immunity. It is a serious 
medical problem particularly in patients in the intensive care unit (ICU)
 
where it is the second 
leading cause of death in non-coronary ICU patients. There is a growing recognition of the need 
for treatment regimens that target both the early systemic and later kidney-specific effects of 
sepsis in patients. Meprins are also capable of proteolytically processing cytokines and 
chemokine. For example, meprin A and meprin α are capable of generating biologically active 
IL-1β from its precursor pro-IL-1β (Herzog C, 2009). Recent studies have demonstrated that 
meprin-α knockout mice were protected against lipopolysaccharide (LPS)-induced AKI (Hewlett 
M. Wagner E., Bloom D., and Camerini D, 2004).  
Data from this study suggests that meprin deficient mice that had undergone CLP 
induced sepsis had less severe kidney damage than WT mice in comparison to their sham 
counterparts. Both WT and αKO mice had higher BUN levels post CLP surgeries. STZ-injected 
WT mice had higher BUN levels post CLP in comparison to the control group. 
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The mechanisms by which meprins protect against sepsis in diabetic nephropathy are not 
fully understood. A potential pathway is through modulation of ECM metabolism. Further 
studies need to be done with meprin knockout mice to further evaluate mechanisms by which 
meprins protect mice from diabetic kidney damage in septic conditions. Having a suitable model 
for DN is critical in advancing research in DN and ultimately identifying biomarkers that can be 
used for early diagnosis of patients at risk for DN. Early diagnosis is important in providing 
targeted treatments to patients and decreasing both mortality and morbidity rates. 
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